Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextromethorphan and Memantine in Bipolar Disorder
NCT03039842Phase 3Unknown
- Sponsor
- National Cheng Kung University Hospital
- Start
- Jan 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dextromethorphan, memantine in Bipolar II disorder (BP-II), sponsored by National Cheng Kung University Hospital. Status: unknown.
02
Drugs
dextromethorphanmemantine
03
Conditions
Bipolar II disorder (BP-II)
Beyond the preview
Go deeper on NCT03039842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03039842.